Griffin, James D.
Harvard Medical School,
United States
2025 Rank: 105662
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1944 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105662 | 120823 |
| Total Cites | 828 | 864 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 35 | 35 |
| Number of Single+First+Last Authored Papers | 242 | 242 |
| Total Cites to Single+First+Last Authored Papers | 399 | 405 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 696 | 722 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
4.17%
|
|
Griffin, James D.
Harvard Medical School,
United States
2024 Rank: 159017
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2993 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159017 | 183310 |
| Total Cites | 883 | 917 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 21 | 21 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 356 | 362 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 782 | 812 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.13 |
| Self-Citation Percentage |
3.71%
|
|
Griffin, James D.
Harvard Medical School,
United States
2023 Rank: 94331
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2010 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94331 | 108338 |
| Total Cites | 1119 | 1178 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 27 | 28 |
| Number of Single+First+Last Authored Papers | 248 | 248 |
| Total Cites to Single+First+Last Authored Papers | 508 | 518 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 938 | 986 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.19 |
| Self-Citation Percentage |
5.01%
|
|
Griffin, James D.
Harvard Medical School,
United States
2022 Rank: 71361
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1730 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71361 | 81122 |
| Total Cites | 1241 | 1323 |
| H-index | 17 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 33 | 36 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 553 | 571 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1072 | 1130 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.17 |
| Self-Citation Percentage |
6.20%
|
|
Griffin, James D.
Dana-Farber Cancer Institute,
United States
2021 Rank: 70723
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1590 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70723 | 79561 |
| Total Cites | 1849 | 1986 |
| H-index | 20 | 21 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 43 | 44 |
| Number of Single+First+Last Authored Papers | 244 | 244 |
| Total Cites to Single+First+Last Authored Papers | 843 | 872 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1558 | 1656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
6.90%
|
|
Griffin, James D.
Dana-Farber Cancer Institute,
United States
2020 Rank: 54127
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1169 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54127 | 59089 |
| Total Cites | 1452 | 1555 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 38 | 38 |
| Number of Single+First+Last Authored Papers | 238 | 238 |
| Total Cites to Single+First+Last Authored Papers | 623 | 641 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1219 | 1293 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
6.62%
|
|